Multicomponent complex formation between pyrimethamine, cyclodextrins and water-soluble polymers

Brazilian Archives of Biology and Technology

Volumn 54, Issue 5, 2011, Pages 965-972

  Rodrigues, Leticia Norma Carpentieri ^a,b   Issa, Michelle Georges ^d   Asbahr, Ana Carolina Cavassin ^b   Silva, Marco Aurélio Carvalho ^c   Ferraz, Humberto Gomes ^d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c POSITIVO UNIVERSITY   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HP CD; Inclusion complexes; Pyrimethamine

Indexed keywords

EID: 81455139982     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132011000500014     Document Type: Article

References (23)

1. Araujo, M.V.G.; Vieira, E.K.B.; Lazaro, G.S.; Conegero, L.S.; Ferreira, O.P.; Almeida, L.E.; Barreto, L.S.; Costa Jr, N.B.; Gimenez, L.E. (2007), Inclusion complexes of pyrimethamine in 2-hydroxypropyl-β-cyclodextrin: Characterization, phase solubility and molecualr modelling. Bioorgan. Med. Chem., 15, 5752-5759.
2. Aronson, H. (1993), Correction factor for dissolution profile calculations. J. Pharm. Sci., 82, 1190.
3. Asbhar, A.C.; Franco, L.; Barison, A.; Silva, C.W.P.; Ferraz, H.G.; Rodrigues L.N.C. (2009), Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization. Bioorgan. Med. Chem., 17, 2718-2723.
4. Bourbigot, S.; Le Bras, M.; Daquesne, S.; Rochery, M. (2004), Recent advances for intumescent polymers. Macromol. Mater. Eng., 289, 499-511.
5. Capello, B.; Carmignani, C.; Iervolino, M.; La Rotonda, M. I.; Saettone, M.F. (2001), Solubilization of tropicamide by hydroxyproyl-β-cyclodextrin and water-soluble polymers: in vitro/in vivo studies. Int. J. Pharm., 213, 75-81.
6. Carrier, R.L.; Miller, L.A.; Ahmed, I. (2007) The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Release, 123, 78-99.
7. Greenwood, B. (2008), Progress in malaria control in endemic areas. Travel medicine and Infectious Disease, 6, 173-176.
8. Higuchi, T.; Connors, K. A. (1965), Advances in analytical chemistry instrumentation. Wiley-Interscience, New York.
9. Jansook, P.; Loftsson, T. (2009), CDs as solubilizers: Effects of excipients and competing drugs. Int. J. Pharm., 379, 1, 32-40.
10. Loftsson, T.; Frioriksdóttir, H.; Siguroardóttir, A.M.; UEDA, H. (1994), The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm., 110, 169-177.
11. Loftsson, T.; Brewster, M. (1996), Pharmaceutical applications of cyclodextrins. 1. Drug solubization and stabilization. J. Pharm. Sci., 85, 1017-1025.
12. Loftsson, T., Fridriksdóttir, H., (1998). The effect of water-soluble polymers on the aqueous solubility and complexing abilities of-cyclodextrin. Int. J. Pharm., 163, 115-121.
13. Loftsson, T.; Másson, M.; Sigurjónsdóttir, J. F. (1999), Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sci., 9, 237-242.
14. Loftsson, T.; Hreinsdóttir, D.; Másson, M. (2005), Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm., 302, 18-28.
15. Loftsson, T.; Hreinsdóttir, D., Másson, M. (2007), The complexation efficiency. Journal of J. Incl. Phenom. Macro., 57, 545-552.
16. Mura, P.; Faucci, M.T.; Bettinetti, G.P. (2001), The influence of polyvinilpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci., 13, 187-194.
17. Partika, M.; Au, B.H.; Evans, C.H. (2001), Cyclodextrins as phtotoxicity inhibitors in drug formulations: studies on model systems involving naproxen and β-cyclodextrin. J. Photoch. Photobio. A., 140, 67-74.
18. Pitha, J.; Milechi, J.; Fales, H.; Pannel, L.; Uekama, K. (1986), Hydroxypropyl-β-cyclodextrin: preparation and characterization: effects on solubility of drugs. Int. J. Pharm., 29, 73-82.
19. Rajewski, R.A.; Stella, V.J. (1996) Pharmaceutical applications of cyclodextrins. 2. In vivo delivery drug delivery, J. Pharm. Sci., 85, 1142-1169.
20. Ribeiro, L.; Ferreira, D.C.; Veiga, F.J.B. (2005) In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J. Control. Release, 103, p. 325-33.
21. Ribeiro, L.; Loftsson, T.; Ferreira, D. and Veiga, F. (2003), Investigation and physicochemical characterization of vimpocetine sulfobutyk ether β-cyclodextrin binary and ternary complexes. Chem. Pharm. Bull., 51, p.914-922.
22. United States Pharmacopoeia (2007), 30 ed., United States Pharmacopeial Convention, Rockville. United States Pharmacopoeia
23. Valero, M.; Esteban, B.; Pelaez, R.; Rodriguez, L.J. (2004), Naproxen: Hydroxyproil-β-Cyclodextrin:Polyvinilpyrrolidone ternary Compex Formation. J. Incl. Phenom. Macro., 48, 157-163.